Pathology AI (Artificial Intelligence) Market Statistics,
Emerging Demands and Forecast

Global Pathology AI (Artificial
Intelligence) market Report from The Delvens highlights deep analysis
on market characteristics, sizing, estimates and growth by segmentation,
regional breakdowns & country along with competitive landscape, Key
Competitors market shares, and strategies that are key to the Global market. In
addition, the study helps venture or private players in understanding the
companies in more detail to make better informed decisions.

The global Pathology AI (Artificial Intelligence) market
size was estimated at USD 23.4 million in 2023 and is projected to reach USD
66.53 billion in 2030 at a CAGR of 16.1% during the forecast period 2023-2030.

Get Free Sample
Report@ https://www.delvens.com/get-free-sample/pathology-ai-market

The AI ​​Pathology Market can be defined as the integration
of AI-based algorithms and machine learning techniques in the world of
pathology. Pathology, a critical discipline in medicine, involves the study of
tissues and cells to diagnose diseases, understand their progression, and guide
treatment decisions. With the advent of artificial intelligence, this
traditional practice is undergoing a profound transformation, supported by
advanced computing capabilities that provide pathologists and healthcare
providers with unprecedented insights.

Increasing government initiatives to encourage healthcare
providers and other healthcare organizations to adopt AI-based diagnostic
technologies, as well as investments by non-profits and private companies for
better data sharing, improved clinical outcomes and cost reduction are some of
the expected key drivers. to boost the growth of the artificial intelligence
pathology market during the forecast period. Additionally, high demand for
e-diagnosis services in healthcare due to increasing government healthcare
expenditure is fueling the market growth.

Competitive Landscape

·       
General Electric Co. (GE Healthcare)

·       
Koninklijke Philips N.V

·       
F. Hoffmann-La Roche Ltd

·       
Hologic, Inc

·       
Akoya Biosciences, Inc

·       
Aiforia

·       
Indica Labs Inc

·       
OptraScan

·       
Ibex Medical Analytics Ltd.

·       
Mindpeak GmbH

·       
Tribun Health

·       
Siemens Healthineers

·       
Zebra Medical Vision, Inc.

·       
Riverain Technologies

·       
IDx Technologies Inc.

·       
NovaSignal Corporation

·       
Vuno, Inc.

·       
Aidoc

·       
Neural Analytics

·       
Imagen Technologies

·       
Digital Diagnostics, Inc.

·       
GE Healthcare

·       
AliveCor Inc.

·       
Proscia Inc

·       
PathAl, Inc.

·       
Tempus Labs, Inc.

For More Inquiry
Contact us@ https://www.delvens.com/Inquire-before-buying/pathology-ai-market

Recent Developments

·       
In April 2023, Indica Labs Inc. signed an
agreement with Lunit Inc. The agreement helped to provide a fully interoperable
solution between Indica Labs’ HALO AP image management software platform and
Lunit’s suite of AI pathology products.

·       
In March 2022, Ibex Medical Analytics Ltd. Had
partnered with Dedalus Group. Through this partnership, the company aimed to
bring the power of artificial intelligence to digital pathology.

North America to
Dominate the Market

·       
North America is estimated to account for the
largest market share during the forecast period. In North America, there is
growing investments and reforms to modernize the pathology infrastructure in
the region and the increasing adoption of digital pathology solutions.

·       
Moreover, the expansion of healthcare
infrastructure and growing market availability of advanced AI technologies.

Regional Level Scope

·       
North America,

·       
Europe,

·       
Asia-Pacific,

·       
South America, and

·       
Middle East, and Africa

Reasons to Acquire

·       
Increase your understanding of the market for
identifying the most suitable strategies and decisions based on sales or
revenue fluctuations in terms of volume and value, distribution chain analysis,
market trends, and factors.

·       
Gain authentic and granular data access for the
Pathology AI (Artificial Intelligence) Market to understand the trends and the
factors involved in changing market situations.

·       
Qualitative and quantitative data utilization to
discover arrays of future growth from the market trends of leaders to market
visionaries and then recognize the significant areas to compete in the future.

Access Full Report@ https://www.delvens.com/report/pathology-ai-market

In addition to the
market data for the Pathology AI (Artificial Intelligence) market, Delvens
offers client-centric reports customized according to the company’s specific
demand and requirements.

Browse Full Report@

Antacids market size was estimated
at USD 7.3 billion in 2023 and is projected to reach USD 10.30 billion in 2030
at a CAGR of 5.04% during the forecast period 2023-2030.

Antibody Drug Conjugates (ADC) market
size was estimated at USD 5.78 billion in 2023 and is projected to reach USD
24.53 billion in 2030 at a CAGR of 22.94% during the forecast period 2023-2030.

Non-Small Cell Lung Cancer (NSCLC) market
size was estimated at USD 15.1 billion in 2023 and is projected to reach USD
28.3 billion in 2030 at a CAGR of 9.40% during the forecast period 2023-2030.

About Us:

Delvens is a strategic advisory and consulting company
headquartered in New Delhi, India. The company holds expertise in providing
syndicated research reports, customized research reports and consulting
services. Delvens qualitative and quantitative data is highly utilized by each
level from niche to major markets, serving more than 1K prominent companies by
assuring to provide the information on country, regional and global business
environment. We have a database for more than 45 industries in more than 115+
major countries globally.

Delvens database assists the clients by providing in-depth
information in crucial business decisions. Delvens offers significant facts and
figures across various industries namely Healthcare, IT & Telecom,
Chemicals & Materials, Semiconductor & Electronics, Energy,
Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our
company provides an exhaustive and comprehensive understanding of the business
environment.

Contact us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-3290-6466

+1 214-377-1144

sales@delvens.com